Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular Permeability

Autor: Nagai, Nori, Ju, Meihua, Izumi-Nagai, Kanako, Robbie, Scott J., Bainbridge, James W., Gale, David C., Pierre, Esaie, Krauss, Achim H.P., Adamson, Peter, Shima, David T., Ng, Yin-Shan
Zdroj: In The American Journal of Pathology September 2015 185(9):2534-2549
Databáze: ScienceDirect